In vivo kinetics of [F‐18]MEFWAY: A comparison with [C‐11]WAY100635 and [F‐18]MPPF in the nonhuman primate
Abstract
[F‐18]Mefway was developed to provide an F‐18 labeled positron emission tomography (PET) neuroligand with high affinity for the serotonin 5‐HT1A receptor to improve the in vivo assessment of the 5‐HT1A system. The goal of this work was to compare the in vivo kinetics of [F‐18]mefway, [F‐18]MPPF, and [C‐11]WAY100635 in the rhesus monkey. Methods: Each of four monkeys were given bolus injections of [F‐18]mefway, [C‐11]WAY100635, and [F‐18]MPPF and scans were acquired with a microPET P4 scanner. Arterial blood was sampled to assay parent compound throughout the time course of the PET experiment. Time activity curves were extracted in the high 5‐HT1A binding areas of the anterior cingulate cortex (ACG), mesial temporal cortex, raphe nuclei, and insula cortex. Time activity curves were also extracted in the cerebellum, which was used as a reference region. The in vivo kinetics of the radiotracers were compared based on the nondisplaceable distribution volume (VND) and binding potential (BPND). Results: At 30 min, the fraction of radioactivity in the plasma due to parent compound was 19%, 28%, and 29% and cleared from the arterial plasma at rates of 0.0031, 0.0078, and 0.0069 (min−1) ([F‐18]mefway, [F‐18]MPPF, [C‐11]WAY100635). The BPND in the brain regions were mesial temporal cortex: 7.4 ± 0.6, 3.1 ± 0.4, 7.0 ± 1.2, ACG: 7.2 ± 1.2, 2.1 ± 0.2, 7.9 ± 1.2; raphe nuclei: 3.7 ± 0.6, 1.3 ± 0.3, 3.3 ± 0.7; and insula cortex: 4.2 ± 0.6, 1.2 ± 0.1, 4.7 ± 1.0 for [F‐18]mefway, [F‐18]MPPF, and [C‐11]WAY100635 respectively. Conclusions: In the rhesus monkey, [F‐18]mefway has similar in vivo kinetics to [C‐11]WAY100635 and yields greater than 2‐fold higher BPND than [F‐18]MPPF. These properties make [F‐18]mefway a promising radiotracer for 5‐HT1A assay, providing higher counting statistics and a greater dynamic range in BPND. Synapse, 2011.Keywords
This publication has 24 references indexed in Scilit:
- Dynamic PET Denoising with HYPR ProcessingJournal of Nuclear Medicine, 2010
- Measurement of Serotonin 5-HT1A Receptor Binding Using Positron Emission Tomography and [carbonyl-11C]WAY-100635—Considerations on the Validity of Cerebellum as a Reference RegionJournal of Cerebral Blood Flow & Metabolism, 2007
- [18F]MPPF as a tool for the in vivo imaging of 5-HT1A receptors in animal and human brainNeuropharmacology, 2006
- Performance evaluation of the microPET P4: a PET system dedicated to animal imagingPhysics in Medicine & Biology, 2001
- Radioligands for the study of brain 5-HT1A receptors in vivo–development of some new analogues of wayNuclear Medicine and Biology, 2000
- An improved one-pot procedure for the preparation of [11C-carbonyl]-WAY100635Nuclear Medicine and Biology, 1999
- Tracer Kinetic Modeling of the 5-HT1AReceptor Ligand [carbonyl-11C]WAY-100635 for PETNeuroImage, 1998
- Identifiability analysis and parameter identification of an in vivo ligand-receptor model from PET dataIEEE Transactions on Biomedical Engineering, 1990
- Dynamic PET Data AnalysisJournal of Computer Assisted Tomography, 1986
- A new look at the statistical model identificationIEEE Transactions on Automatic Control, 1974